BR0010916A - ácido nucleico, sonda ou iniciador de nucleotìdeo, processos e kits para amplificação de um ácido nucleico, para detecção de presença de um ácido nucléico e de um polipeptìdeo, para seleção de uma molécula ou de uma substância candidata que interage com um polipeptìdeo, vetor recombinante, célula hospedeira recombinante, polipeptìdeo, e, anticorpo - Google Patents

ácido nucleico, sonda ou iniciador de nucleotìdeo, processos e kits para amplificação de um ácido nucleico, para detecção de presença de um ácido nucléico e de um polipeptìdeo, para seleção de uma molécula ou de uma substância candidata que interage com um polipeptìdeo, vetor recombinante, célula hospedeira recombinante, polipeptìdeo, e, anticorpo

Info

Publication number
BR0010916A
BR0010916A BR0010916-9A BR0010916A BR0010916A BR 0010916 A BR0010916 A BR 0010916A BR 0010916 A BR0010916 A BR 0010916A BR 0010916 A BR0010916 A BR 0010916A
Authority
BR
Brazil
Prior art keywords
nucleic acid
polypeptide
recombinant
kits
antibody
Prior art date
Application number
BR0010916-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Requingne
Catherine Prades
Christian Clepet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9906587A external-priority patent/FR2794131B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR0010916A publication Critical patent/BR0010916A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR0010916-9A 1999-05-25 2000-05-25 ácido nucleico, sonda ou iniciador de nucleotìdeo, processos e kits para amplificação de um ácido nucleico, para detecção de presença de um ácido nucléico e de um polipeptìdeo, para seleção de uma molécula ou de uma substância candidata que interage com um polipeptìdeo, vetor recombinante, célula hospedeira recombinante, polipeptìdeo, e, anticorpo BR0010916A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906587A FR2794131B1 (fr) 1999-05-25 1999-05-25 Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol
US13945099P 1999-06-16 1999-06-16
PCT/FR2000/001426 WO2000071710A2 (fr) 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol

Publications (1)

Publication Number Publication Date
BR0010916A true BR0010916A (pt) 2002-02-19

Family

ID=26234967

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010916-9A BR0010916A (pt) 1999-05-25 2000-05-25 ácido nucleico, sonda ou iniciador de nucleotìdeo, processos e kits para amplificação de um ácido nucleico, para detecção de presença de um ácido nucléico e de um polipeptìdeo, para seleção de uma molécula ou de uma substância candidata que interage com um polipeptìdeo, vetor recombinante, célula hospedeira recombinante, polipeptìdeo, e, anticorpo

Country Status (11)

Country Link
EP (1) EP1183350A2 (fr)
JP (1) JP2003518918A (fr)
KR (1) KR20020033627A (fr)
AU (1) AU4931800A (fr)
BR (1) BR0010916A (fr)
CA (1) CA2371500A1 (fr)
HU (1) HUP0203164A2 (fr)
IL (1) IL145835A0 (fr)
MX (1) MXPA01011882A (fr)
NO (1) NO20015729L (fr)
WO (1) WO2000071710A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617122B1 (en) 1999-03-15 2003-09-09 Xenon Genetics, Inc. Process for identifying modulators of ABC1 activity
WO2002010388A2 (fr) * 2000-08-01 2002-02-07 Amgen Inc. Molecules du type recepteur de complement c3b/c4b et utilisations de ces molecules
AT413701B (de) * 2001-11-06 2006-05-15 Bmt Medizinische Forschung Und Strukturelle und funktionelle charakterisierung von cdw92
US20100111851A1 (en) 2007-01-05 2010-05-06 The University Of Tokyo Diagnosis and treatment of cancer by using anti-prg-3 antibody
CN104109208A (zh) 2007-11-14 2014-10-22 中外制药株式会社 使用抗gpr49抗体的癌症的诊断和治疗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020165A2 (fr) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Marqueurs bialleliques

Also Published As

Publication number Publication date
KR20020033627A (ko) 2002-05-07
AU4931800A (en) 2000-12-12
NO20015729D0 (no) 2001-11-23
MXPA01011882A (es) 2002-05-06
JP2003518918A (ja) 2003-06-17
WO2000071710A3 (fr) 2001-05-17
EP1183350A2 (fr) 2002-03-06
IL145835A0 (en) 2002-07-25
CA2371500A1 (fr) 2000-11-30
WO2000071710A2 (fr) 2000-11-30
NO20015729L (no) 2002-01-22
HUP0203164A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
Fu et al. The human LON protease binds to mitochondrial promoters in a single-stranded, site-specific, strand-specific manner
Helm et al. A Watson− Crick Base-pair-disrupting methyl group (m1A9) is sufficient for cloverleaf folding of human mitochondrial tRNALys
Ren et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
Hu et al. Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis
Hwang et al. p48 Activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity
Dranoff et al. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells
Charlton et al. Highly Potent Irreversible Inhibitors of Neutrophil Elastase Generated by Selection from a Randomized DNA− Valine Phosphonate Library
CN101892305B (zh) 高血压易感基因的rs2295281位点的检测方法及检测试剂盒
Kemp et al. An alternative form of replication protein a expressed in normal human tissues supports DNA repair
Potaman et al. Specific binding of poly (ADP-ribose) polymerase-1 to cruciform hairpins
Uchiumi et al. The role of TFAM-associated proteins in mitochondrial RNA metabolism
Kikuchi et al. Genome-wide analysis of epigenetic signatures for kidney-specific transporters
Stathopoulou et al. A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C [S]
Jian-Gang et al. Apolipoprotein E and longevity among Han Chinese population
US20140128455A1 (en) Diagnosis and treatment of friedreich's ataxia
Dave et al. Reprogrammable recognition codes in bicoid homeodomain-DNA interaction
Mayerle et al. Slow formation of stable complexes during coincubation of minimal rRNA and ribosomal protein S4
BR0010916A (pt) ácido nucleico, sonda ou iniciador de nucleotìdeo, processos e kits para amplificação de um ácido nucleico, para detecção de presença de um ácido nucléico e de um polipeptìdeo, para seleção de uma molécula ou de uma substância candidata que interage com um polipeptìdeo, vetor recombinante, célula hospedeira recombinante, polipeptìdeo, e, anticorpo
Spangler et al. Activation of adenovirus promoters by the adenovirus E1A protein in cell-free extracts
Ma et al. Molecular characterization of the porcine GBP1 and GBP2 genes
Tai et al. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation
Shirakawa et al. Nuclear accumulation of HMG2 protein is mediated by basic regions interspaced with a long DNA-binding sequence, and retention within the nucleus requires the acidic carboxyl terminus
Tucker et al. Role of the ATP synthase α-subunit in conferring sensitivity to tentoxin
CN101210268B (zh) 一种检测巯基嘌呤甲基转移酶基因型的试剂盒及方法
Faniello et al. Bilateral cataract in a subject carrying a C to A transition in the L ferritin promoter region

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.